Genesystem Co., Ltd. (KOSDAQ:363250)
3,940.00
+40.00 (1.03%)
At close: Nov 13, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 32.65 billion as of November 13, 2026. It is the 35,272nd most valuable company in the world and the 2,071st biggest in South Korea. Its market cap has decreased by 15.58% in one year.
Market Cap
32.65B
Enterprise Value
31.56B
Revenue
1.01B
Global Rank
Country Rank
#2,071 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 32.65B, a decrease of -72.45%. That is a compound annual growth rate of -20.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 32.65B | 16.75% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DRGEM | 53.61B |
| Dynamic solution | 50.20B |
| JPI Healthcare | 38.90B |
| Genoray | 37.62B |
| BTB Korea Co.,Ltd | 37.35B |
| QuantaMatrix | 36.18B |
| UXN Co., Ltd. | 29.07B |
| Noul Co.,Ltd. | 24.36B |